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Abstract
Stirred tank bioreactors are still the predominant cultivation systems in large scale bio-
pharmaceutical production. Today, several manufacturers provide both reusable and 
single-use systems, whereas the broad variety of designs and properties lead to devia-
tions in biological performance. Although the methods for bioreactor characterization 
are well established, varying experimental conditions and procedures can result in sig-
nificantly different outcomes. In order to guarantee a reliable comparison and evaluation 
of different single-use and reusable bioreactor types, standardized methods for their 
characterization are needed. Equally important is the biological capability of bioreactors, 
which must be accessed by standardized cultivation procedures of industrially relevant 
organisms (bacteria, yeasts as well as mammalian and animal cell cultures). In addition, 
the implementation of well-defined uniform procedures for biological and engineering 
characterization during the development phase can support a fast assessment of the suit-
ability of a bioreactor system. Based on stirred bioreactors, we describe the aspects of the 
engineering characterization in order to discuss further the biological characterization as 
a valuable complement. Finally, a case study is presented.
Keywords: stirred bioreactor, characterization, mixing time, power input, volumetric 
mass transfer coefficient, development, cultivation system
1. Introduction
Stirred bioreactor systems have been used on a large scale since the beginning of antibiot-
ics and insulin production, and are indispensable in biopharmaceutical production today 
[1]. They are the most frequently used bioreactor systems as they are suitable for various 
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expression systems, currently using predominantly recombinant Escherichia coli (E. coli) 
strains or Chinese hamster ovary (CHO) cell lines [2–7].
Stirred bioreactors are available as reusable systems made of steel and glass or as single-use 
systems in different sizes. Many well-known manufacturers offer standard stainless steel sys-
tems with volumes from 2 to 1000 L, whereby larger systems with several cubic meters are also 
available according to customer specifications. The smaller scale glass bioreactors are used in 
research and process development [8]. The single-use systems, depending on their size, are 
either available as flexible bags or rigid vessels. They have become increasingly established 
in recent years and have found their way into biopharmaceutical productions with volumes 
of up to 2000 L. Eibl et al. [9] gives an overview of the currently available single-use systems.
In addition to the economic reasons for choosing one of the many reusable or single-use sys-
tems, they have to meet the requirements of the desired fermentation process. The design and 
equipment of stirred bioreactors differ in terms of their performance. The efficiency of the 
bioreactor is described with the help of process engineering parameters [10, 11]. Therefore, 
the mixing time θ
m
 of the system, the volumetric mass transfer coefficient k
L
a and the specific 
power input P/V are determined. This enables a comparison of different bioreactor types and 
the definition of suitable process parameters to achieve the desired product quality and quan-
tity [12].
A new approach based on process engineering characterization is the biological characteriza-
tion. This may be a standardized E. coli model process enabling a reveal in the performance 
limits of the bioreactor system.
It will be shown that process engineering characterization in combination with biological 
characterization is a simple standardized approach, which is not only necessary for the evalu-
ation of existing bioreactor types, but also makes a valuable contribution during the develop-
ment phase of new systems.
2. Theoretical background
The bioreactors used for the cultivation of microorganisms, mammalian and animal cells differ 
from reactors in the chemical industry in their aspect ratio (H/D). While H/D ratios of 1:1 occur 
in chemical production, these are usually 2:1 for bioreactors for cell cultures and 3:1 for micro-
organisms. The background to this is the longer residence time of oxygen or process air intro-
duced into the system near the reactor bottom and the better temperature control due to the 
larger ratio of surface to volume [6, 10, 13]. However, with increasing reactor size, H/D ratios of 
up to 5:1 also occur [14]. For the cylindrical bioreactor vessel, the shape of the upper and lower 
end elements is also crucial. Curved heads with geometries from a hemisphere to a flat plate 
are used, whereby the dished head is the most common element. The reasons for this are the 
higher durability compared to planar end elements, and the geometry-related lower overall 
height compared to hemispherical elements. By avoiding dead zones and edges, cleaning of 
the system (hygienic design) and mixing is also favored. The upper end is usually a flat lid, 
which facilitates accessibility for the installation of probes or correction agents and feed [15, 16].
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2.1. Agitation
Besides the vessel geometry, the impeller is the central element of the bioreactor. The choice 
of the right agitator organ has a decisive influence on the success of cultivation, as it prevents 
local sources and sinks. It is now possible to choose from a variety of different impeller designs, 
while taking into account the type of microorganism, human or animal cell line to be cultivated. 
Shear-sensitive cell culture processes are characterized by low energy and low oxygen input 
(P/V ≈ 5–200 W·m−3/OTR ≈ 0.5–8 mmol O
2
·L−1·h−1) as well as small cooling capacities. Axial flow 
impellers are often used for this purpose. For most applications with microorganisms, how-
ever, especially in the high cell density range (≈ 100 g·L−1 dry cell weight), higher specific power 
inputs and oxygen transfer rates are required (P/V > 5 kW·m−3 / OTR ≈ 300–500 mmol O
2
·L−1·h−1). 
For this purpose, radial flow impellers are used. Higher energy inputs lead to an improved 
gas dispersion and thus to higher oxygen transfer rates [6, 7, 10, 17–24]. Zlokarnik [19] and 
Mirro & Voll [17] provide an overview of the impeller types frequently used, and their field 
of application for the cultivation of various microbial and animal cell lines. Therefore, the pro-
cess properties, in particular the mixing time, volumetric mass transfer coefficient and power 
input in combination with the resulting shear gradient are decisive for the impeller design to 
be selected [25]. Depending on the application and bioreactor size, multi-stage configurations 
with combinations of radial and axial flow impellers are also possible.
2.2. Drive
Traditionally, the agitator is driven via a centrally mounted shaft with the aid of a motor 
located above or below the bioreactor. The feedthrough of the shaft into the bioreactor has to 
be sealed. In the simplest case, a single-acting mechanical seal reduces the escape of organ-
isms from the bioreactor, but bears the risk of contamination [16]. For reasons of product 
safety, as well as maintaining a tight containment, double mechanical seals are predominantly 
used. Two pairs of sliding rings are arranged one behind the other and form an intermedi-
ate space through which a barrier fluid flows. The pressurized barrier liquid, which is often 
sterile condensate, prevents leakage from the fermenter [26]. Magnetic couplings offer an 
alternative to complex double-acting mechanical seals. The magnetic field transfers the torque 
from the motor through the closed bioreactor to the impeller. The risk of contamination is 
further decreased by contactless power transmission [13]. In industrial applications, both 
free-floating and bearing-supported impellers can be found. Bearing-supported impellers are 
manufactured by MAVAG AG, Millipore Corporation and ZETA Holding GmbH, among oth-
ers. The impeller with one part of the magnetic coupling sits on a bearing journal where the 
second part of the magnetic coupling is also located. The mounting is often done by means of 
ceramic plain bearings [27–29]. However, friction with insufficient lubrication may result in 
attrition of the material [30]. The levitation technology is used, for example, by Sartorius AG 
and Pall AG for mixing systems. Only the impeller with one part of the magnetic coupling is 
located in the vessel. The magnetic field applied causes the impeller to lift off the bottom of 
the container. This simple type of drive does not require a bearing, and is therefore ideally 
suited for use in single-use systems, whereas radially acting forces are difficult to absorb [31, 
32]. As shown in our case study (see Section 3.1), the levitation technology is also suitable for 
new stirred bioreactors.
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2.3. Characterization according to parametric and experimental approaches
Due to the large number of bioreactors available and their different process engineering prop-
erties, the choice of the right system for the requirements of a desired and successful process is 
decisive. The process engineering characterization allows the comparison of different systems 
and supports process optimization and scale-up strategies by using parametric as well as 
experimental approaches [11, 12]. Therefore in January 2016, DECHEMA issued a recom-
mendation with standardized methods for obtaining reliable experimental data, which can be 
applied to both reusable and single-use bioreactor systems [33].
The dimensionless Reynolds number describes the ratio of inertial to viscous forces in a flow 
and describes it as laminar, transient or turbulent (Re
crit
 1–10·104) [34, 35]. For stirred bioreactor 
systems, the Reynolds number can be determined parametrically as a function of the impeller 
speed N, the impeller diameter d, the density ρ and the viscosity η according to Eq. (1).
  Re =  
ρ · N ·  d 2 
 _______η (1)
Another parameter is the maximum fluid velocity (u
max
), which usually corresponds to the tip 
speed u
tip
 (Eq. (2)).
  u 
tip
  = π · d · N (2)
In order to avoid sources and sinks in the bioreactor, a homogeneous distribution of all com-
ponents is required. A benchmark of homogeneity is the mixing quality, which is regarded as 
adequate at 95% [36]. The mixing time θ
m
 defines the time required after adding a disturbance 
variable to the system (e.g. change in temperature, concentration, conductivity or density) to 
achieve the required mixing quality [12, 35, 36]. Eq. (3) applies in completely turbulent flows, 
in which case the mixing number c
H
 is calculated according to Eq. (4).
  θ 
m
  ∝  (P / V) −1/3 (3)
  c 
H
  =  θ 
m
 · N = const. (4)
One of the most important parameters is the specific power input P/V, as this is responsible 
for maintaining sufficient mixing and mass transfer. There are several methods for determin-
ing the power input. The most common is the direct torque measurement [12, 37]. For the 
calculation according to Eq. (5), the effective impeller torque (difference between the torque 
when stirring in liquid M and the dead torque in air M
d
) will be measured by means of a 
torque sensor. If a DC motor with a known motor torque constant K
t
 is used, it is also possible 
to determine the respective torque by measuring the required current I and using Eq. (6) [38].
  P / V =   (M −  M d ) · 2 · π · N  ______________
V
 (5)
  M =  K 
t
 · I (6)
Biopharmaceuticals90
Oxygen supply is essential for aerobic cultivation processes. This is ensured by the use of 
spargers, gassing via membranes or the fluid surface [21, 39]. The oxygen transition is defined 
by the oxygen transfer rate (OTR) and depends on the mixing efficiency, the power input, the 
gassing rate and the fluid properties [40, 41]. It results from the product of the mass transfer 
coefficient k
L
 and the volume-specific interface area a as well as the oxygen concentration dif-
ference  C 
 O 
2
 
 ∗ −  C 
 O 
2
 
 as the driving force (Eq. (7)).
  
d  C 
 O 
2
 
 
 ____
dt
  = OTR =  k 
L
  a ·  ( C  O 2  ∗ −  C  O 2  ) (7)
2.4. Characterization by biological approaches
Biological characterization focuses on the evaluation and comparison of bioreactor systems 
with respect to their biological performance. With the help of a model organism, it should 
be possible to make an exact prediction of the suitability of a bioreactor system for a desired 
purpose with a standardized cultivation procedure [42]. For example, two biological test 
procedures with respiratory yeast and mycelium-forming fungi were developed by Adler 
and Fiechter [43] and Wagner [44], since the physical characterization often only provides 
information about optimal bioreactor design conditions and information for improved scale 
transfer. For this reason, DECHEMA’s ‘Single-use technology in biopharmaceutical production’ 
working group is currently working on a new standardized procedure for the biological 
characterization of classical stirred bioreactors and single-use systems using batch and fed-
batch cultivations in addition to the recommendation for process engineering characteriza-
tion. Escherichia coli W3110 is used as a model organism. This is a subspecies of the E. coli 
K12 strain, which is one of the most frequently used and best characterized microorganisms. 
The suitability of E. coli as a model organism can be explained by its high availability, short 
generation time and extensively investigated growth behavior as well as its high relevance in 
the biopharmaceutical industry [20, 45, 46].
3. Case study
In this case study, the methodical procedures described above are used to develop a bearing-
free magnetically driven 2 L benchtop bioreactor system, which is based on Levitronix’s freely 
levitating impeller technology.
3.1. Bioreactor and setup
The use of a magnetic drive without bearings enables the establishment of a seal-free, con-
tactless and magnetically mounted bottom impeller, which offers an almost unlimited speed 
range and a minimized risk of contamination (Figure 1).
The impeller levitating in the bioreactor at the bottom creates a constant gap, which is made 
possible by the passive stabilization of the stirring element by a constantly changing magnetic 
field [47, 48]. For design reasons, a flat end element was chosen for the bottom, into which the 
BPS-i30 and BPS-i100 drives from Levitronix GmbH were introduced for the investigations. A 
glass cylinder with a diameter of 124.5 mm and a planar lid with nozzles for probes and the 
Development, Engineering and Biological Characterization of Stirred Tank Bioreactors
http://dx.doi.org/10.5772/intechopen.79444
91
possibility of adding correction agents and feed solutions was mounted on top of it. The impel-
lers used for the BPS-i30 drive are the geometries shown in Figure 2 with diameters of 20, 30, 
40 and 50 mm and, based on this, 40, 50, 60 and 74 mm for the more powerful BPS-i100 drive. 
The oxygen input was made possible by means of a ring sparger with holes facing upwards. 
The temperature was controlled by using an electric heating and a water-flow cooling finger.
3.2. Process engineering characterization
All process engineering parameters to be investigated were determined by means of design 
of experiments, and the experimental data were evaluated using MODDE 10.1 (Umetrics, 
Sweden).
3.2.1. Power input
The specific power input (non-gassed conditions) was determined with water at a constant 
temperature of 25°C, and a maximum working volume according to Ref. [33]. Because of the 
constructive conditions of the vessel and motor geometry, the sensor method for determining 
the torque was not applicable. Due to the known motor constants K
t
 with 1.13 and 2.0 Ncm·A−1 
(BPS-i30/BPS-i100), the torque can be recalculated with the desired current for agitation using 
Eqs. (5) and (6). Likewise, the examined torque of the empty vessel (dead weight torque) was 
subtracted from the measured torque of the filled vessel.
Figure 2. Magnetic impeller with increasing blade diameter.
Figure 1. Setup and design of 2 L vessel (left) and construction of the designed impeller unit in the bioreactor bottom 
plate (right).
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Additionally, the torque was determined by numerical simulations (computational fluid 
dynamics (CFD)). Based on the predicted fluid flow, the power inputs of the impellers were 
obtained from the torque acting on the impeller and the shaft. Therefore, the fluid flow inside 
the bioreactor equipped with the different impellers was modeled using the finite volume 
solver ANSYS Fluent (ANSYS Inc., Version 16.2, USA) by using the realizable k-ϵ turbulence 
model for water at 25°C [49]. The vessel walls and the impeller were treated as non-slip 
boundaries with standard wall functions. The axial velocity at the fluid surface was set to 
zero. All equations were discretized using the first-order upwind scheme and the COUPLED 
algorithm was chosen for pressure-velocity coupling. The fluid domain was discretized by an 
unstructured mesh consisting of about 8×106 to 11×106 tetrahedrons.
3.2.2. Mixing time
The mixing times were examined by the decolorization method (iodometry) at maximum 
working volume according to [33]. Therefore, the bioreactor was filled with water and 2 mL·L−1 
iodine potassium iodide solution (potassium iodide 40 g·L−1, iodine 20 g·L−1) and 5 mL·L−1 
starch solution (1% w/v) were added under agitation at a constant temperature of 25°C. After 
ensuring a completely homogeneous chemical solution and a quasi-stationary fluid flow pat-
tern, 4 mL·L−1 sodium thiosulfate solution were added and the time was measured until the 
color change from dark blue to colorless was achieved.
3.2.3. Volumetric mass transfer coefficient
The k
L
a values were determined by the gassing-out method with phosphate-buffered saline 
(PBS) at 37°C for gassing rates between 0.5 and 2 vvm with a maximum working volume 
according to Ref. [33]. An OIM-PSt3 probe in combination with a prototype sensor (OEC-
PSt3-UF) without protection membrane (PreSens GmbH, Germany, sensor response time 4 s) 
was used for measurement of dissolved oxygen DO. For a measurement, a quasi-stationary 
fluid flow pattern was ensured and the dissolved oxygen in the PBS in the bioreactor was 
eliminated by introducing nitrogen. Afterwards, the data acquisition was started, the nitro-
gen supply stopped, the process air supply set to the desired aeration rate and the aeration 
started. The measurement was completed when a saturated oxygen concentration had been 
reached, indicated by a stable DO value of 100%. The evaluation and calculation of the k
L
a 
value according to Meusel et al. [33] was done for a DO saturation rate between 10 and 90%.
3.3. Biological characterization
Based on the results of the process engineering characterization, the process parameters for 
the E. coli cultivations were set to values resulting in the highest k
L
a values by maintaining 
a constant gassing and tip speed of 2 vvm (process air) and 7000 and 2900 rpm (20 mm – 
BPS-i30/40 mm – BPS-i100). Therefore, a cryopreserved culture of E. coli W3110 thyA36 supO 
λ- (ATCC: 27325) was incubated for 24 h at 37°C on lysogenic broth (LB) agar. Pre-culture 1 
(1-L baffled shake flask, Corning, USA) was inoculated in 200 mL LB medium with one colony 
from the petri dish and incubated for 8 h at 37°C in a shaking incubator.
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The second pre-culture was also incubated in a 1-L shake flask with 150 mL medium at an 
initial optical density at 600 nm (OD600) of 0.1 for 16 h at 30°C in a shaker. The medium of the 
second pre- and main culture correspond to the composition described by Biener et al. [50] with 
concentrations (g·L−1): glucose (pre-culture 2: 10, batch: 80 and fed-batch: 20), MgSO
4
·7H
2
O 
(0.54), (NH
4
)
2
H-citrat (1.01), Na
2
SO
4
 (2.02), (NH
4
)
2
SO
4
 (4.03), NH
4
Cl (0.51), K
2
HPO
4
 (15.17), 
NaH
2
PO
4
·H
2
O (3.55), CaCl
2
·2H
2
O (2.25 10−3), ZnSO
4
·7H
2
O (0.81·10−3), MnSO
4
·H
2
O (0.45·10−3), 
Na
2
-EDTA·2H
2
O (45·10−3), FeCl
3
·6H
2
O (37.6·10−3), CuSO
4
·5H
2
O (0.72·10−3) and CoCl
2
·6H
2
O 
(0.81·10−3).
For the fed-batch process, a concentrated feed with a high glucose concentration was added 
into the bioreactor after the initial glucose had depleted. To maintain a constant growth rate, 
an exponential profile was used [51, 52]. The feed medium was formulated with the following 
concentrations (g·L−1): glucose (655.3), MgSO
4
·7H
2
O (16.02), CaCl
2
·2H
2
O (43·10−3), ZnSO
4
·7H
2
O 
(15·10−3), MnSO
4
·H
2
O (85·10−3), Na
2
-EDTA·2H
2
O (85·10−3), FeCl
3
·6H
2
O (71·10−3), CuSO
4
·5H
2
O 
(14·10−3) and CoCl
2
·6H
2
O (15·10−3). In contrast to the batch process, the DO was regulated by 
the substitution of process air with pure oxygen.
The batch fermentations had a starting volume of 2 L, whereas the fed-batch started with 
1.3 L to ensure an appropriate covering of all sensors and heating and cooling devices. After 
reaching an OD600 of 150, a second feed with (NH
4
)
2
HPO
4
 was immediately added to a con-
centration of 4 g·L−1 to the bioreactor. The pH was regulated automatically by adding 20% 
(w/w) ammonia solution and foaming was controlled by the addition of 1:5 diluted Antifoam 
204 (Sigma-Aldrich). Cultivations were terminated at DO ≈ 0%.
3.4. Results
In the run-up to the experimental investigations, the new bioreactor system with the mag-
netic drive was numerically examined with regard to the process engineering parameters 
regarding its suitability for the cultivation of microorganisms. As expected, the specific power 
input shows an exponential increase with rising rotational speed (Figure 3). However, it also 
becomes apparent that with the weaker BPS-i30 drive, only the impellers with a diameter of 20 
and 30 mm are in the range of microbial requirements with P/V > 5 kW·m−3 and u
tip
 > 1.5 m·s−1 
[10]. With the more powerful BPS-i100 drive, this is the case for all impellers.
The experimentally determined specific power inputs show only minor deviations compared 
to the numerically determined values, whereby larger differences result in increasing rota-
tional speed. The largest deviation for the 20 mm impeller at 7000 rpm (u
tip
 = 7.3 m·s−1) is 
around 3.5 kW·m−3. This circumstance can result from the radial forces not taken into account 
in the simulations, which increase with rising rotational speed due to possible impeller imbal-
ances. Therefore, in the present case, the power inputs are estimated as slightly too low with 
the help of the CFD.
With regard to the mixing time, Figure 4 shows that all impellers with a specific power input 
of 1 kW·m−3 and above meet a required mixing time of θ
m
 < 10 s [53]. A turbulent flow regime 
with Re > Re
crit
 is also present from this value on (see Table 1). The slope of the regressions of 
the mixing times is between −0.19 and − 0.4, which is close to the theoretical value of −0.33 (see 
Eq. (3)). Thus, mixing numbers in the range of 65–183 result according to Eq. (4).
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The experimentally determined k
L
a values for the two impellers 20 and 40 mm (BPS-i30/
BPS-i100) are shown in Figure 5. The values explain the highest volumetric mass trans-
fer coefficients found at the highest possible rotational speeds of 7000 and 2900 rpm 
(14.3 kW·m−3/24.4 kW·m−3) (see Table 1). The strong influence of the impeller speed becomes 
clear, as at low rotational speeds most of the gas reaches the fluid surface with very low dis-
persion due to the insurmountable buoyancy force of the introduced gas. This effect is often 
also referred to as “flooding” [35, 54], whereby in the present bioreactor design, the impeller 
running on the bottom does not pull down the bubbles emerged by the higher lying sparger, 
and is therefore not able to disperse them sufficiently due to radially acting forces. Compared 
with experiments on the 30 and 100 L scale, the value determined with the 20 mm impeller is 
three times smaller [42].
Based on the process engineering investigations, the cultivation for biological characterization 
was carried out. The impellers 20 and 40 mm (BPS-i30/BPS-i100) used demonstrated identical 
behavior during the process up to hour 6 with respect to biomass, glucose and acetate concen-
trations as well as in the DO profile (see Figure 6). This can also be seen in the growth rates, 
which after approximately 3 h reach a value of μ ≈ 0.4 h−1. Due to the high glucose concentra-
tion, which inhibits growth with values of more than 50 g·L−1 [24], the maximum growth rate 
Figure 3. Double logarithmic representation of the numerically and experimentally determined P/V values for all used 
impellers as a function of N (left: BPS-i30/right: BPS-i100). P/V, specific power input; N, impeller speed.
Figure 4. Double logarithmic representation of the experimentally determined θ
m
 values for all impellers used as a 
function of P/V (left: BPS-i30/right: BPS-i100). θ
m
, mixing time; P/V, specific power input.
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of 0.61 h−1 for this E. coli strain is not reached [45]. From hour 6, the use of the smaller impeller 
shows a successive decrease in the growth rate and a faster increase in acetate. This effect is 
ascribed to the lower oxygen content in the medium and a so-called salt effect by the increased 
addition of base, which could be observed during fermentation [24, 55–57]. This finally leads 
to a decrease in growth and glucose consumption, as acetate concentrations from 2 g·L−1 can 
have an inhibiting effect [58]. Thus, when using the smaller impeller, an OD600 of 35.4 ± 0.1 
or a dry cell weight DCW of 13.0 ± 1.8 g·L−1 is achieved. When using the larger impeller in 
combination with a more powerful drive and a resulting higher k
L
a value, an optical density 
of 65.3 ± 3.4 (21.6 ± 1.9 g·L−1 DCW) is reached.
Figure 5. Representation of the experimentally determined k
L
a values (n = 5) as a function of N and β (left: BPS-i30, 
20 mm, R2 = 0.76/right: BPS-i100, 40 mm, R2 = 0.96). k
L
a, volumetric mass transfer coefficient; N, impeller speed; β, gassing 
rate.
Impeller diameter [mm] BPS-i30 BPS-i100 Re at P/V of 1 W·m−3
N
max
 [rpm] k
L
a [h−1] N
max
 [rpm] k
L
a [h−1]
20 7000 206 — — ≈ 19,900
30 3150 142 — — ≈ 25,400
40 1700 172 2900 694 ≈ 30,000
50 1100 170 1900 657 ≈ 34,000
60 — — 1400 560 ≈ 37,000
74 — — 1250 591 ≈ 52,200
k
L
a, volumetric mass transfer coefficient; N
max
, maximum impeller speed; Re, Reynolds number; P/V, specific power 
input.
Table 1. Representation of the highest experimentally determined k
L
a values (n = 5) for both drive systems used with the 
corresponding maximum impeller speeds and Reynolds numbers of the different impellers at a P/V of 1 W·m−3.
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In reusable pilot bioreactors for microbial applications with 30 and 100 L previously tested, 
only optical densities of 39 ± 5 at higher oxygen transport rates of 735 and 745 h−1 were obtained 
[42]. This fact can only be attributed to the considerably shorter mixing times of 2.77 and 3.47 s 
(20 mm/40 mm) in the 2 L scale shown here. These were determined in the mentioned larger 
systems with 8–10 s. The additional oxygen uptake rate OUR determined during cultivation 
with the 40 mm impeller shows a maximum of 256 mmol·L−1·h−1 (see Figure 6).
The results of the fed-batch cultivations with the BPS-i100 system presented in Figure 7 show 
an expected higher biomass concentration with an OD600 of 262.4 ± 0.3, which corresponds 
to a DCW of 86.6 ± 1.9 g·L−1. Due to the lower glucose concentration in the starting medium, a 
growth rate of >0.6 h−1 could be achieved after 3 h. With a further steady decrease in glucose 
concentration, the growth rate drops to values between 0.3 and 0.4 h−1, which were controlled 
by exponential feed addition. The feed was started between hours 6 and 7 since the glucose in 
the medium was depleted at this time, which is also expressed by the corresponding DO peak. 
To keep the oxygen content constant at 40% during the further cultivation, the process air was 
gradually substituted with oxygen from hour 7 on. From hour 12.5 on, 2 vvm pure oxygen 
was required. Interestingly, after a cultivation time of 11.5 h, there were signs of insufficient 
cooling of the system, as the bioreactor temperature rose steadily to a maximum of 40.7°C by 
the end of the cultivation.
Figure 6. Determined biomass profiles for OD600 and DCW (top left), glucose and acetate concentrations (top right) 
and DO profiles as well as the growth rates (bottom left) over the process time from the batch cultures (n = 2) when 
using impellers with a diameter of 20 and 40 mm (BPS-i30/BPS-i100). The lower right diagram shows the OUR and CER 
determined in the exhaust air over the cultivation time for the latter bioreactor configuration (40 mm). OD600, optical 
density; DCW, dry cell weight; DO, dissolved oxygen; μ, growth rate; OUR, oxygen uptake rate; CER, carbon dioxide 
formation rate.
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4. Discussion
The determined process engineering parameters demonstrate that the newly developed bio-
reactor system can be used for the cultivation of shear-sensitive animal cells as well as micro-
bial cells up to the high cell density range. In this way, the process engineering parameters 
for all impellers with specific power inputs of up to 500 W·m−3 show suitability for animal 
cell culture processes. The k
L
a values are within a range of 20 and 100 h−1, and the resulting 
mixing times are ≤10 s. These are also typical values described in the literature for animal cell 
culture bioreactors, such as the Finesse SmartGlass bioreactor [59], the Mobius CellReady 3 L 
bioreactor [60] or the reusable BIOSTAT UniVessel and BIOSTAT UniVessel SU [11]. A first 
proof of concept batch cultivation with CHO XM 111-10 suspension cells (SEAP secreting 
cell line, the secreted alkaline phosphatase of the placenta, CCOS No. 837) in a chemically 
defined minimal medium using the BPS-i30 drive resulted in middle cell densities of up to 
4·106 cells·mL-1(data not shown), which are in the same order of magnitude as in the previ-
ously mentioned bioreactors, and in the BioBlu 0.3c as well as BIOSTAT® A [61–66]. Taking 
into account the shear stress acting on the cells, theoretically higher cell densities may also 
be achievable, since the performance limits of the system have not been reached, and can be 
complemented by suitable feeding strategies.
In addition, due to the simple design of the system, with the elimination of seals and bear-
ings, by using a magnetic drive with a freely levitating impeller the bioreactor is almost 
maintenance-free and the risk of contamination is reduced. It also facilitates cleaning and the 
Figure 7. Certain biomass profiles for OD600 and DCW (top left), glucose and acetate concentrations (top right) and DO 
profile as well as the growth rates (bottom left) over the process time from the fed-batch cultures (n = 2) using the impeller 
with a diameter of and 40 mm (BPS-i100). The lower right diagram shows the temperature curve in the bioreactor over 
the cultivation time. OD600, optical density; DCW, dry cell weight; DO, dissolved oxygen; μ, growth rate.
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easy and fast change of impeller types for different applications. Furthermore, the bioreactor 
system offers a high turn down ratio allowing an easy-to-scale process.
While conventional microbial processes can also be implemented with the less powerful BPS-
i30 drive, the BPS-i100 in combination with the 40 mm impeller is recommended for high cell 
density microbial processes. This is demonstrated by nearly a doubling of the optical densities 
in the E. coli batch cultivations, and the results of the fed-batch procedure.
So it comes as no surprise that the specific power inputs obtained in the case study with the 
new bioreactor provide comparable results to other microbial bioreactor systems described 
in the literature. For bioreactors with sizes of 1–100 L, these are between 2.5 and 20 kW·m−3 
[42, 67–69], whereby a minimum requirement of >5 kW·m−3 is generally assumed [10]. The 
achieved mixing numbers are partly c
H
 > 100 due to the impeller position at the vessel bottom, 
which are above the usual values for bioreactors equipped with different impeller types [35]. 
Mixing times are also below the 10 s recommended for microbial requirements [53], as is also 
the case in other conventional bioreactors up to pilot scale [42, 70, 71]. However, compared to 
systems with larger volumes, a possible increase in mixing time of up to 2 min must also be 
taken into account [10]. According to manufacturers and previously published data, for several 
bioreactors k
L
a values between 300 and 745 h−1 are reached and are sufficient for microbial 
processes with a resulting OTR from 250 to 500 mmol·L−1·h−1 [20, 42, 67, 69, 70, 72–74]. Against 
this background, only the impellers with the BPS-i100 drive shown in the case study appear to 
be relevant for microbial industrial processes. The impellers driven on the bioreactor bottom 
with the weaker BPS-i30 drive are not able to disperse the gas bubbles sufficiently. In conven-
tional bioreactors, this problem is circumvented by the fact that the impellers are located above 
the aeration organ. So far, the fed-batch cultures have shown, one of the main problems of 
microbial high cell density cultures is the removal of the heat generated in the system, which 
means that this either has to be countered with larger heat exchange surfaces or lower coolant 
temperatures [10]. Nevertheless, with the performed fed-batch model process, a higher cell 
density (>260) could be achieved as in other microbial systems. These given results of OD600 
values between 100 and 201 in a very similar high-demanding E. coli process [67, 70, 72, 74, 75].
5. Conclusion
The combination of DECHEMA’s recommendation for process engineering characteriza-
tion and the E. coli standard model process described above provides an easy-to-implement 
approach for the standardized qualification of existing microbial bioreactor systems, and 
for those currently under development, as shown for the novel benchtop-scale bioreactor 
equipped with Levitronix’s magnetic drives.
The investigated process engineering parameters allow the estimation of its optimal working 
areas and limits. In addition, it allows a selection of a suitable impeller design to increase the 
productivity of biopharmaceutical processes. The impeller with a diameter of 40 mm in com-
bination with the more powerful BPS-i100 drive shows the highest k
L
a value and a mixing time 
of <4 s at the highest specific power input of 24.4 kW·m−3. In line with expectations, the largest 
biomass with an optical density of 65.3 in batch mode and 262.4 in fed-batch mode is achieved. 
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Surprisingly, the use of the smallest impeller with the smaller BPS-i30 drive shows a comparable 
biomass concentration to bioreactors on a pilot scale despite a very low k
L
a value for microbial 
processes. This circumstance is not foreseeable by the sole process engineering characterization, 
so that the additional use of a biological characterization approach becomes evident. The suit-
ability of the presented developed bioreactor concept for microbial applications could be clearly 
demonstrated, even if it seems rather unusual in comparison to commercial systems due to its bot-
tom drive without bearings. The complete characterization provides the possibility for an easier 
transfer to the industrial biopharmaceutical scale. Finally, the currently available bioengineering 
data of the new developed bioreactor indicate that the bioreactor operated with the BPS-i30 drive 
can also be used to grow animal cells. More detailed investigations are planned in the future.
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